CRISPR and Genome Editing – Products

The Sapio Platform is the first AI-native lab informatics solution to unify ELN, LIMS, and SDMS into a single platform, supporting R&D, clinical, and manufacturing labs by streamlining scientific workflows and standardizing data.

A no-code, science-aware ELN for modern labs. Sapio ELN supports structured and free-form experiments, AI-native assistance, and deep integration with LIMS and SDMS to streamline workflows and enable faster, more reproducible research

TQ Therapeutics acquires Juno Therapeutics GmbH, expanding its cell therapy platform and access to key intellectual property.

Telesis Bio and Regeneron collaborate to deploy the Gibson SOLA™ platform, enabling faster, automated gene synthesis to accelerate drug discovery.

CytoPak single-use bags support closed-system CGT manufacturing with weldable tubing, ready-to-use format, and optimized cytokine dosing—ensuring sterility, consistency, and scalability from research to commercial production.

Circio Holding ASA (OSE: CRNA), announces the presentation of new and strengthened in vivo data at the American Society of Gene and Cell Therapy (ASGCT) annual meeting 2025 in New Orleans, USA.

Bionova licenses ATUM’s Leap-In tech to speed up cell line development and streamline biologics manufacturing.

Atelerix partners with MineBio to bring its pioneering hydrogel-based cell preservation technology to China, enhancing biotech logistics and reducing costs.

Terumo BCT and KBIOHealth have signed an MOU to develop workforce training for cell and gene therapy manufacturing in Korea. The program will focus on CAR-T and MSC therapy production using automated systems like Quantum Flex.

AMSBIO has launched GMP grade StemFit® for Differentiation - a chemically defined and animal component-free formulation that enables unmatched differentiation of human Induced Pluripotent Stem (hiPS) and Embryonic Stem (hES) cells.